Antibacterial company Entasis proposes NASDAQ IPO

Entasis Therapeutics Inc. (Waltham, Mass.) proposed on Friday to raise $86.3 million in an IPO on NASDAQ underwritten by Credit Suisse, BMO Capital Markets, SunTrust Robinson